Hypnotics and Sedatives

REFERENCES

• Schlag, J.: A study of the action of Nembutal on diencephalic and mesencephalic activity. Arch, internat. pharmacodyn. 64:470–488, 1956.
   Google Scholar
• Goodnow, R. E., Beecher, H. K., Brazier, M. A. B., Mosteller, F. and Tagiuri, R.: Physiological performance following a.hypnotic dose of a barbiturate. J. Pharmacol. & Exper. Therap. 102:55–61, 1951.
   PubMed Web of Science ®Google Scholar
• Cahn, C. H.: The effect of drugs on group therapy: An experiment. J. Nerv. & Ment. Dis. 118:516–526, 1953.
   PubMed Web of Science ®Google Scholar
• Hughes, J. G., Ehemann, B. and Brown, U. A.: Electroencephalography of the newborn: III. Brain potentials of babies born of mothers given “seconal sodium.” Am. J. Dis. Child. 76:626–633, 1948.
   Google Scholar
• Keats, A. S. and Beecher, H. K.: Pain relief with hypnotic doses of barbiturates and a hypothesis. J. Pharmacol. & Exper. Therap. 100:1–13, 1950.
   PubMed Web of Science ®Google Scholar
• Harris, T. D. and Borison, H. L.: Effect of pentobarbital on electrical excitability of respiratory center in the cat. Am. J. Physiol. 176:77–82, 1954.
   PubMed Web of Science ®Google Scholar
• Burstein, C. L. and Rovenstine, E. A.: Respiratory parasympathetic actions of some shorter acting barbituric acid derivatives. J. Pharmacol. & Exper. Therap. 63:42–50, 1938.
   Google Scholar
• Murtagh, J. A. and Campbell, C. J.: Laryngeal spasm. In: Transactions of the American. Laryngological, Rhinological and Otological Society, 58th Meeting, 1954, pp. 39–56.
   Google Scholar
• McCall, M. L. and Taylor, H. W.: Effects of barbiturate sedation on the brain in toxemia of pregnancy. J. A.M. A. 149:51–54, 1952.
   PubMed Web of Science ®Google Scholar
• Winchell, P., Taylor, H. L. and Chapman, C. B.: The effect of Amytal on the cardiac output a.d peripheral resistance of man. Circulation 4:229–232. 1951.
   PubMed Web of Science ®Google Scholar
• Page, I. H., Del Greco, F. and Corcoran, A. C.: Effects of pentobarbital anesthesia, high spinal cord section and large doses of ganglioplegic agents on hemodynamic functions measured by dye dilution. Am. J. Physiol. 179:601–606, 1954.
   PubMed Web of Science ®Google Scholar
• Kirkecaard, A. and Nørregaard, S.: Electrocardiograms in severe acute barbiturate intoxication. Nord, med. 44:1954–1959, 1950.
   PubMedGoogle Scholar
• McCrory, C. B. and Virtue, R. W.: Comparative effects of anesthetic agents on incidence of ventricular fibrillation during hypothermia. Proc. Soc. Exper. Biol. & Med. 90:327–329, 1955.
   PubMed Web of Science ®Google Scholar
• Landgren, S., Liljestrand, G. and Zotterman, Y.: Impulse activity in carotid sinus nerve following in-acarotid injections of sodium-iodo-acetate, histamine hydrochloride, lergitin, and some purine and barbituric acid derivatives. Acta physiol. scandinav. 30:149–160, 1954.
   PubMedGoogle Scholar
• Schneider, R. A.: The acute effects of reserpine and of Amytal on central sympathetic reactivity. Ann. New York Acad. Sc. 61:150–160, 1955.
   PubMed Web of Science ®Google Scholar
• Frew, J. L. and Rosenheim, M. L.: The labile neurogenic component of hypertension. A comparison of the effects of tetra-ethyl-ammonium bromide and a rapidly acting barbiturate (Seconal). Clin. Sc. 7:217–229, 1949.
   PubMed Web of Science ®Google Scholar
• Lous, P.: Plasma levels and urinary excretion of three barbituric acids after oral administration to man. Acta pharmacol. et toxicol. 10:147–165, 1954.
   PubMedGoogle Scholar
• Maynert, E. W. and Van Dyke, H. B.: The metabolism of barbiturates. Pharmacol. Rev. 1:217–242, 1949.
   PubMed Web of Science ®Google Scholar
• Maynert, E. W.: The distribution and fate of diallbarbiturates. Fed. Proc. 11:625–631, 1952.
   PubMedGoogle Scholar
• Brodie, B. B.: Physiological disposition and chemical fate of thiobarbiturates in the body. Fed. Proc. 11:632–639, 1952.
   PubMedGoogle Scholar
• Richards, R. K. and Taylor, J. D.: Some factors influencing distribution, metabolism and action of 1-barbiturates: A review. Anesthesiology 17:414–458, 1956.
   PubMed Web of Science ®Google Scholar
• Isbell, H. and Fraser, H. F.: Addiction to analgesics and barbiturates. Pharmacol. Rev. 2:355–397, 1950.
   Web of Science ®Google Scholar
• Gruber, C. M. and Keyser, G. F.: A study on the development of tolerance and cross tolerance to barbiturates in experimental animals. J. Pharmacol. & Exper. Therap. 86:186–196, 1946.
   PubMed Web of Science ®Google Scholar
• Sterling, J. A. and Shaw, D.: Respiratory arrest following small quantity of barbiturate. J. Albert Einstein M. Center 4:64–65, 1956.
   PubMedGoogle Scholar
• Tatum, A. L.: The present status of the barbiturate problem. Physiol. Rev. 19:427–502, 1939.
   Google Scholar
• Michelson, A. L., Frahm, C. J. and Katz, K. H.: Delayed barbiturate intoxication. J.A.M.A. 155:440. 441, 1954.
   PubMed Web of Science ®Google Scholar
• Fazekas, J. F. and Koppanyi, T.: Prevention and treatment of acute barbiturate intoxication. GP 6:79–84, 1952.
   PubMedGoogle Scholar
• Berman, L. B., Jeghers, H. J., Schreiner, G. E. and Pallotta, A. J.: Hemodialysis, an effective therapy for acute barbiturate poisoning. J.A.M.A. 161:820–827, 1956.
   PubMed Web of Science ®Google Scholar
• Mousel, L. H.: Cerebral edema and its relation to larbituric acid poisoning. J.A.M.A. 153:459–462, 1953.
   Web of Science ®Google Scholar
• Wikler, A., Fraser, H. F., Isbell, H. and Pescor, F. T.: Electroencephalograms during cycles of addiction to barbiturates in man. Electroencephalog. & Clin. Neurophysiol. 7:1–13, 1955.
   PubMedGoogle Scholar
• Merritt, H. H. and Putnam, T. J.: A new series of anticonvulsant drugs tested by experiments on animals. A.M.A. Arch. Neurol. & Psychiat. 34: 1003–1015, 1938.
   Google Scholar
• ll, A. V. and Macpherson, L.: The effect of certain anions on the duration of the active state in skeletal muscle. J. Physiol. 125:17P–18P, 1954.
   PubMed Web of Science ®Google Scholar
• Kahn, A. J. and Sandow, A.: Effects of bromide, nitrate and iodide on responses of skeletal muscle. Ann. New York Acad. Sc. 62:139–175, 1956.
   Web of Science ®Google Scholar
• Brattgard, S.-O. and Lindqvist, T.: Intracellular localisation of 82Br in nerve cells. J. Neurol. Neurosurg. & Psychiat. 17:11–13, 1954.
   PubMed Web of Science ®Google Scholar
• Hunter, G., Smith, H. V. and Taylor, L. M.: On the bromide test of permeability of the barrier between blood and cerebrospinal fluid: An assessment. Biochem. J. 56:588–597, 1954.
   PubMed Web of Science ®Google Scholar
• Wolf, R. L. and Eadie, G. S.: Reabsorption of bromides by the kidney. Am. J. Physiol. 163:436–441, 1950.
   PubMed Web of Science ®Google Scholar
• Davenport, H. W. and Fisher, R. B.: The mechanism of the secretion of acid by the gastric mucosa. Am. J. Physiol. 131:165–175, 1940.
   Google Scholar
• Quastel, J. H. and Yates, E. D.: Removal of bromine from the blood in cases of mental disorder. Biochem. J. 28:1530–1535, 1934.
   PubMedGoogle Scholar
• Pine, I., Rinear, L. L. and Parker, M. M.: Abnormal distortions of the electroencephalogram in psychiatric patients. South. M. J. 48:286–291, 1955.
   PubMedGoogle Scholar
• Owens, A. H., Jr., Marshall, E. K., Jr., Broun, G. O., Jr., Zubrod, C. G. and Lasagna, L.: A comparative evaluation of the hypnotic potency of chloral hydrate and trichloroethanol. Bull. Johns Hopkins Hosp. 96:71–83, 1955.
   PubMedGoogle Scholar
• Muller, S. A. and Fisch, C.: Cardiac arrhythmia due to use of chloral hydrate. J. Indiana M. A. 49: 38–40, 1956.
   Google Scholar
• Christianson, H. B. and Perry, H. O.: Reactions to chloral hydrate. A.M.A. Arch. Dermat. 74:232–240, 1956.
   Google Scholar
• Butler, T. C.: Reduction and oxidation of chloral hydrate by isolated tissues in vitro. J. Pharmacol. & Exper. Therap. 95:360–362, 1949.
   PubMed Web of Science ®Google Scholar
• Agranat, A. L. and Trubshaw, W. H.: The danger of decomposed paraldehyde. South African M. J. 29:1021–1022, 1955.
   PubMedGoogle Scholar
• Figot, P. P., Hine, C. H. and Way, E. L.: The estimation and significance of paraldehyde levels in blood and brain. Acta pharmacol. et toxicol. 8:290–304, 1952.
   PubMedGoogle Scholar
• Gruber, C. M., Jr., Kohlstaedt, K. G., Moore, R. B. and Peck, F. B., Jr.: A study of the effects of Valmid, a nonbarbiturate central nervous system depressant, in humans. J. Pharmacol. & Exper. Therap. 112:480–483, 1954.
   PubMed Web of Science ®Google Scholar
• Lasagna, L.: A study of hypnotic drugs in patients with chronic diseases. Comparative efficacy of placebo; methyprylon (Noludar); meprobamate (Miltown, Equanil); pentobarbital; phenobarbital; secobarbital. J. Chron. Dis. 3:122–133, 1956.
   PubMedGoogle Scholar
• Reidt, W. U.: Fatal poisoning with methyprylon (Noludar). New England J. Med. 225:231–232, 1956.
   Web of Science ®Google Scholar
• Randall, L. O., Iliev, V. and Brandman, O.: Metabolism of methyprylon. Arch, internat, pharmacodyn. 106:388–394, 1956.
   PubMedGoogle Scholar
• Ladwig, H. A.: An electroencephalographic study of Doriden. A.M.A. Arch. Neurol. & Psychiat. 74: 351–355, 1955.
   PubMedGoogle Scholar
• Gerster, P., Scholer, H. and Züger, M.: Klinische Beobachtungen bei einer akuten Vergiftung mit α-Phenyl-α-äthylglutarimid (Doriden). Schweiz, med. Wchnschr. 85:991–994, 1955.
   PubMedGoogle Scholar
• McBay, A. J. and Katsas, G. G.: Glutethimide poisoning. A report of four fatal cases. New England J. Med. 257:97–100, 1957.
   PubMed Web of Science ®Google Scholar